KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Deferred Taxes (2016 - 2023)

Humana (HUM) has disclosed Deferred Taxes for 13 consecutive years, with -$67.0 million as the latest value for Q4 2022.

  • On a quarterly basis, Deferred Taxes fell 546.67% to -$67.0 million in Q4 2022 year-over-year; TTM through Sep 2023 was -$252.0 million, a 36.22% decrease, with the full-year FY2024 number at -$192.0 million, down 14.97% from a year prior.
  • Deferred Taxes was -$67.0 million for Q4 2022 at Humana, up from -$200.0 million in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $387.0 million in Q2 2018 to a low of -$469.0 million in Q3 2018.
  • A 5-year average of -$7.4 million and a median of -$1.5 million in 2020 define the central range for Deferred Taxes.
  • Biggest YoY gain for Deferred Taxes was 1333.33% in 2018; the steepest drop was 937.5% in 2018.
  • Humana's Deferred Taxes stood at -$29.0 million in 2018, then skyrocketed by 586.21% to $141.0 million in 2019, then skyrocketed by 40.43% to $198.0 million in 2020, then plummeted by 92.42% to $15.0 million in 2021, then plummeted by 546.67% to -$67.0 million in 2022.
  • Per Business Quant, the three most recent readings for HUM's Deferred Taxes are -$67.0 million (Q4 2022), -$200.0 million (Q3 2022), and $15.0 million (Q4 2021).